Correction: Roncoroni, L. et al. A low FODMAP gluten-free diet improves functional gastrointestinal disorders and overall mental health of celiac disease patients: A randomized controlled trial. (Nutrients (2018), 10, 1023, 10.3390/nu10081023);A low FODMAP gluten-free diet improves functional gastrointestinal disorders and overall mental health of celiac disease patients: A randomized controlled trial

Nutrients

Volumn 10, Issue 8, 2018, Pages

  Roncoroni, Leda ^a,b   Bascuñán, Karla A ^a,c   Doneda, Luisa ^b   Scricciolo, Alice ^a   Lombardo, Vincenza ^a   Branchi, Federica ^a   Ferretti, Francesca ^a   Dell’osso, Bernardo ^b,d   Montanari, Valeria ^a   Bardella, Maria Teresa ^a   Elli, Luca ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF CHILE   (Chile)

^d STANFORD UNIVERSITY   (United States)

Author keywords

Gastrointestinal symptoms; Gluten free diet; Quality of life

Indexed keywords

ABDOMINAL PAIN; ADULT; ARTICLE; CELIAC DISEASE; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL DISEASE; GLUTEN FREE DIET; HUMAN; MALE; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; DIET THERAPY; DIGESTION; DOUBLE BLIND PROCEDURE; FERMENTATION; HEALTH STATUS; ITALY; LOW CARBOHYDRATE DIET; MENTAL HEALTH; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGY; REMISSION; TIME FACTOR; TREATMENT OUTCOME;

ADULT; CELIAC DISEASE; DIET, CARBOHYDRATE-RESTRICTED; DIET, GLUTEN-FREE; DIGESTION; DOUBLE-BLIND METHOD; FEMALE; FERMENTATION; HEALTH STATUS; HUMANS; ITALY; MALE; MENTAL HEALTH; MIDDLE AGED; QUALITY OF LIFE; REMISSION INDUCTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 85051302462     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu11030566     Document Type: Erratum

References (36)

1. De Re, V.; Magris, R.; Cannizzaro, R. New Insights into the Pathogenesis of Celiac Disease. Front. Med. 2017, 4. [CrossRef] [PubMed]
2. Lebwohl, B.; Sanders, D.S.; Green, P.H.R. Coeliac disease. Lancet 2017. [CrossRef]
3. Karell, K.; Louka, A.S.; Moodie, S.J.; Ascher, H.; Clot, F.; Greco, L.; Ciclitira, P.J.; Sollid, L.M.; Partanen, J. HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: Results from the European genetics cluster on celiac disease. Hum. Immunol. 2003, 64, 469–477. [CrossRef]
4. Leffler, D.A.; Green, P.H.R.; Fasano, A. Extraintestinal manifestations of coeliac disease. Nat. Rev. Gastroenterol. Hepatol. 2015, 12, 561–571. [CrossRef] [PubMed]
5. Bascuñán, K.A.; Vespa, M.C.; Araya, M. Celiac disease: Understanding the gluten-free diet. Eur. J. Nutr. 2016, 1–11. [CrossRef] [PubMed]
6. Francavilla, R.; Cristofori, F.; Stella, M.; Borrelli, G.; Naspi, G.; Castellaneta, S. Treatment of celiac disease: From gluten-free diet to novel therapies. Minerva Pediatr. 2014, 66, 501–516. [PubMed]
7. Hauser, W.; Stallmach, A.; Caspary, W.F.; Stein, J. Predictors of reduced health-related quality of life in adults with coeliac disease. Aliment Pharmacol. Ther. 2007, 25, 569–578. [CrossRef] [PubMed]
8. Passananti, V.; Siniscalchi, M.; Zingone, F.; Bucci, C.; Tortora, R.; Iovino, P.; Ciacci, C. Prevalence of eating disorders in adults with celiac disease. Gastroenterol. Res. Pract. 2013, 2013. [CrossRef] [PubMed]
9. O’Leary, C.; Wieneke, P.; Buckley, S.; O’Regan, P.; Cronin, C.C.; Quigley, E.M.M.; Shanahan, F. Celiac disease and irritable bowel-type symptoms. Am. J. Gastroenterol. 2002, 97, 1463–1467. [CrossRef] [PubMed]
10. Sainsbury, A.; Sanders, D.S.; Ford, A.C. Prevalence of irritable bowel syndrome-type symptoms in patients with celiac disease: A meta-analysis. Clin. Gastroenterol. Hepatol. 2013, 11, 359–365. [CrossRef] [PubMed]
11. Quigley, E.M.M. Prokinetics in the Management of Functional Gastrointestinal Disorders. Curr. Gastroenterol. Rep. 2017, 19, 53. [CrossRef] [PubMed]
12. Marsh, A.; Eslick, E.M.; Eslick, G.D. Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis. Eur. J. Nutr. 2016, 55, 897–906. [CrossRef] [PubMed]
13. Gibson, P.R.; Shepherd, S.J. Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach. J. Gastroenterol. Hepatol. 2010, 25, 252–258. [CrossRef] [PubMed]
14. De Roest, R.H.; Dobbs, B.R.; Chapman, B.A.; Batman, B.; O’Brien, L.A.; Leeper, J.A.; Hebblethwaite, C.R.; Gearry, R.B. The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: A prospective study. Int. J. Clin. Pract. 2013, 67, 895–903. [CrossRef] [PubMed]
15. Shepherd, S.J.; Parker, F.C.; Muir, J.G.; Gibson, P.R. Dietary Triggers of Abdominal Symptoms in Patients with Irritable Bowel Syndrome: Randomized Placebo-Controlled Evidence. Clin. Gastroenterol. Hepatol. 2008, 6, 765–771. [CrossRef] [PubMed]
16. Varjú, P.; Farkas, N.; Hegyi, P.; Garami, A.; Szabó, I.; Illés, A.; Solymár, M.; Vincze, Á.; Balaskó, M.; Pár, G.; et al. Low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet improves symptoms in adults suffering from irritable bowel syndrome (IBS) compared to standard IBS diet: A meta-analysis of clinical studies. PLoS ONE 2017, 12. [CrossRef] [PubMed]
17. Halmos, E.P.; Power, V.A.; Shepherd, S.J.; Gibson, P.R.; Muir, J.G. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology 2014, 146, 67–75. [CrossRef] [PubMed]
18. Schumann, D.; Klose, P.; Lauche, R.; Dobos, G.; Langhorst, J.; Cramer, H. Low fermentable, oligo-, di-, mono-saccharides and polyol diet in the treatment of irritable bowel syndrome: A systematic review and meta-analysis. Nutrition 2018, 45, 24–31. [CrossRef] [PubMed]
19. Pedersen, N.; Ankersen, D.V.; Felding, M.; Wachmann, H.; Végh, Z.; Molzen, L.; Burisch, J.; Andersen, J.R.; Munkholm, P. Low-FODMAP diet reduces irritable bowel symptoms in patients with inflammatory bowel disease. World J. Gastroenterol. 2017, 23, 3356–3366. [CrossRef] [PubMed]
20. Ball, A.J.; Hadjivassiliou, M.; Sanders, D.S. Is gluten sensitivity a no man’s land or a fertile crescent for research. Am. J. Gastroenterol. 2010, 105, 222–223. [CrossRef] [PubMed]
21. El-Salhy, M. Irritable bowel syndrome: Diagnosis and pathogenesis. World J. Gastroenterol. 2012, 18, 5151–5163. [CrossRef] [PubMed]
22. Drossman, D.A.; Dumitrascu, D.L. Rome III: New standard for functional gastrointestinal disorders. J. Gastrointest. Liver Dis. 2006, 15, 237–241.
23. Leffler, D.A.; Dennis, M.; Edwards George, J.B.; Jamma, S.; Magge, S.; Cook, E.F.; Schuppan, D.; Kelly, C.P. A Simple Validated Gluten-Free Diet Adherence Survey for Adults with Celiac Disease. Clin. Gastroenterol. Hepatol. 2009, 7. [CrossRef] [PubMed]
24. Husby, S.; Koletzko, S.; Korponay-Szabo, I.R.; Mearin, M.L.; Phillips, A.; Shamir, R.; Troncone, R.; Giersiepen, K.; Branski, D.; Catassi, C.; et al. Nutrition European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J. Pediatr. Gastroenterol. Nutr. 2012, 54, 136–160. [CrossRef] [PubMed]
25. Faul, F.; Erdfelder, E.; Lang, A.-G.; Buchner, A. G*Power: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav. Res. Methods 2007, 39, 175–191. [CrossRef] [PubMed]
26. McIntosh, K.; Reed, D.E.; Schneider, T.; Dang, F.; Keshteli, A.H.; De Palma, G.; Madsen, K.; Bercik, P.; Vanner, S. FODMAPs alter symptoms and the metabolome of patients with IBS: A randomised controlled trial. Gut 2017, 66, 1241–1251. [CrossRef] [PubMed]
27. Muir, J.G.; Rose, R.; Rosella, O.; Liels, K.; Barrett, J.S.; Shepherd, S.J.; Gibson, P.R. Measurement of short-chain carbohydrates in common Australian vegetables and fruits by high-performance liquid chromatography (HPLC). J. Agric. Food Chem. 2009, 57, 554–565. [CrossRef] [PubMed]
28. Biesiekierski, J.R.; Rosella, O.; Rose, R.; Liels, K.; Barrett, J.S.; Shepherd, S.J.; Gibson, P.R.; Muir, J.G. Quantification of fructans, galacto-oligosacharides and other short-chain carbohydrates in processed grains and cereals. J. Hum. Nutr. Diet. 2011, 24, 154–176. [CrossRef] [PubMed]
29. Derogatis, L.R. Symptom Checklist-90-R (SCL-90-R): Administration, Scoring, and Procedures Manual; NCS Pearson: Minneapolis, MN, USA, 1994.
30. Ware, J.J.; Sherbourne, C. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med. Care 1992, 30, 473–483. [CrossRef] [PubMed]
31. Elli, L.; Tomba, C.; Branchi, F.; Roncoroni, L.; Lombardo, V.; Bardella, M.T.; Ferretti, F.; Conte, D.; Valiante, F.; Fini, L.; et al. Evidence for the presence of non-celiac gluten sensitivity in patients with functional gastrointestinal symptoms: Results from a multicenter randomized double-blind placebo-controlled gluten challenge. Nutrients 2016, 8, 84. [CrossRef] [PubMed]
32. Addolorato, G.; Capristo, E.; Ghittoni, G.; Valeri, C.; Mascianà, R.; Ancona, C.; Gasbarrini, G. Anxiety but not depression decreases in coeliac patients after one-year gluten-free diet: A longitudinal study. Scand. J. Gastroenterol. 2001, 36, 502–506. [CrossRef] [PubMed]
33. Gearry, R.B.; Irving, P.M.; Barrett, J.S.; Nathan, D.M.; Shepherd, S.J.; Gibson, P.R. Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease-a pilot study. J. Crohns Colitis 2009, 3, 8–14. [CrossRef] [PubMed]
34. Cossu, G.; Carta, M.G.; Contu, F.; Mela, Q.; Demelia, L.; Elli, L.; Dell’Osso, B. Coeliac disease and psychiatric comorbidity: Epidemiology, pathophysiological mechanisms, quality-of-life, and gluten-free diet effects. Int. Rev. Psychiatry 2017, 29, 489–503. [CrossRef] [PubMed]
35. Kovács, Z.; Seres, G.; Kerékgyártó, O.; Czobor, P. Psychopathological symptom dimensions in patients with gastrointestinal disorders. J. Clin Psychol Med Settings 2010, 17, 378–386. [CrossRef] [PubMed]
36. Johnston, S.D.; Rodgers, C.; Watson, R.G.P. Quality of life in screen-detected and typical coeliac disease and the effect of excluding dietary gluten. Eur. J. Gastroenterol. Hepatol. 2004, 16, 1281–1286. [CrossRef] [PubMed]